Bioventus Inc (BVS) is a Healthcare · Medical Devices company listed on NASDAQ. Price $12.91 (+2.22%), Market cap $0.71B, P/E ratio 25.61, 52-week low–high $6.14 ~ $10.92.
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for p
Financial statements, price targets, institutional (13F) holdings and related news for Bioventus Inc are updated in real time on BlackAll Trade.
Bioventus Inc trades at $12.91 (+2.22%). Real-time quotes and charts are available on BlackAll Trade.
Bioventus Inc has a market cap of about $0.71B. Its P/E ratio is 25.61.
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain tre